Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q2 2021 call → NOThe question asks whether management conveys that the business is currently outgrowing the company's own size — that current activity/demand/commitments are large relative to how small the company still is. Looking at the transcript, management discusses: - Medicare enrollment growth of 30% in Q2 - Online applications growing 80% year-over-year - IFP members growing 78% - Revenue of $96.6 million - 877,000 Medicare members But does management convey disproportion between company size and what's arriving? The company is a leading Medicare distribution platform with 877,000 members, $322 million trailing 12-month commission cash collections. It's not a small company relative to what it's doing. Management talks about growth and strong results, but doesn't frame it as "we are small and what's happening to us is disproportionately large." The growth percentages are strong but management presents them as normal strong growth, not as something outsized relative to a small base. The company has been in business for decades, has hundreds of millions in revenue, and is a major player. Management doesn't convey that the current business is outgrowing the company's size — they talk about scaling operations, hiring agents, and managing growth, which is the opposite of being overwhelmed by demand relative to smallness. Answer: NO
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.